Logibec Inc. (Logibec) today announced that it has entered into an Asset Purchase Agreement to acquire QoC Health, an Ontario-based company. This transaction supports Logibec’s growth in Canada and consolidates its innovative position in the healthcare sector by adding virtual care solutions to its offering.
“We are convinced that this acquisition will accelerate our potential for innovation in the healthcare network through new mobile and cloud solutions,” said Marc Brunet, President, and CEO of Logibec. “Our success in the future depends on our ability to integrate our solutions between care teams and their patients throughout the care trajectory in a way that’s meaningful,” he added.
QoC Health focuses on improving access to care by connecting patients at home with their care team through mobile and web solutions. The principal QoC product is Cloud Connect, a healthcare web services platform. This platform allows healthcare organizations to rapidly deploy patient-centered solutions across many different settings, from primary care and acute care to rehabilitation and chronic care. The QoC platform supports solutions such as post-discharge monitoring, educational tools, and decision aids; it takes the complexity out of developing and deploying cloud-based compliant technology solutions and accelerates next-generation connected healthcare solutions by putting them into the hands of patients across Canada. QoC Health solutions are currently used by multiple customers in Canada and in the United States.
“We are very excited to join the Logibec team as we share the same vision in virtual and connected care. More specifically, by connecting patients living in their community with their healthcare team, so that they can receive the care they need,” said Sarah Harvey, Ph.D., CEO and Co-Founder of QoC Health.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The QoC Health team of experts is immediately joining the Logibec operations team to allow customers of both companies to reap the benefits of this transaction.
Source: Biospace